This is what's known as an opportunity:
As concerns have grown about the increase in drug-resistant and potentially deadly bacterial infections, the pharmaceutical pipeline for new antibiotics has been drying up.
Faced with high research costs and greater profits to be made from other types of medications, many big pharmaceutical companies began abandoning the field of antibiotic development years ago.
This has resulted in a significant slowdown in the introduction of new antibiotics now needed to protect the public health.
More
2 comments:
"Faced with high research costs and greater profits to be made from other types of medications, many big pharmaceutical companies began abandoning the field of antibiotic development years ago."
Who is to blame for the current environment? I know that public interest groups like Sidney Wolfe, Dir of Public Citizen, would like to blame big pharma themself, but....or, "if only drugmakers would put the billions spent on marketing into R&D." Ha! Ha!
It's called ROI!!!!!!!!!!!!!!!!
Ask Cubist Pharma--millions spent developing CUBICIN, yet Managed Care reserves payment only for MRSA.
Sidney Wolf & other anti-drug company activists--when your children are dying from resistant strains--remember--you get what you prayed--i mean paid--for!
With Reservations,
David J Phillips, Publisher
www.10qdetective.blogspot.com
http://pharmagossip.blogspot.com/2007/11/is-fda-raising-safety-bar-and-approving.html
Thanks for visiting David.
Post a Comment